Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $56.97 | $18.32 | 210.97% | 237.38x | 17.19x | 17.41x | 46.66x | 1.12x | $41.15M | 0.82% | $108.58M | 1.23 | $5.02B | 93.80 | ||
| SLNO | SOLENO THERAPEUTICS INC | $53.01 | $59.72 | -11.23% | 28.65x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.95 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $286.27 | $94.41 | 203.23% | 65.66x | 38.82x | 8.87x | 35.54x | 1.35x | $641.34M | 1.69% | $1.08B | 8.09 | $39.48B | 42.71 | ||
| CORT | CORCEPT THERAPEUTICS INC | $55.12 | $18.88 | 191.90% | 119.83x | 105.27x | 7.49x | 9.27x | 1.13x | $119.79M | 2.08% | $637.99M | 6.11 | $5.82B | -847.38 | ||
| KRYS | KRYSTAL BIOTECH INC | $291.75 | $95.86 | 204.36% | 37.65x | 36.08x | 20.48x | 6.74x | 1.79x | $237.38M | 2.78% | $1.28B | 43.59 | $8.11B | 37.90 | ||
| ADMA | ADMA BIOLOGICS INC | $8.38 | $10.51 | -20.24% | 12.14x | 8.44x | 3.88x | 4.98x | 0.41x | $107.90M | 5.45% | $390.33M | 1.65 | $2.00B | 9.04 | ||
| OMER | OMEROS CORP | $11.70 | $15.56 | -24.80% | 9.00x | -30.72x | 84.78x | -13.37x | 0.45x | -$94.78M | -11.26% | -$63.33M | -0.88 | $1.16B | 12.78 | ||
| ASND | ASCENDIS PHARMA A | $237.64 | $83.95 | 183.08% | 25.19x | 19.13x | 14.49x | 25.71x | 2.34x | $52.94M | 0.36% | $574.09M | 9.24 | $15.14B | 162.36 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.01 | $2.83 | 112.36% | 85.86x | 50.29x | 3.26x | 79.75x | 0.82x | $47.52M | 4.64% | $13.01M | 0.08 | $1.18B | 22.17 | ||
| VCEL | VERICEL CORP | $34.87 | $9.16 | 280.87% | 81.09x | 72.33x | 6.06x | 5.00x | 1.71x | $47.49M | 2.68% | $356.23M | 7.02 | $1.77B | 43.69 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.43 | $16.30 | -35.99% | 5.09x | 22.20x | 4.98x | 3.00x | 0.64x | $56.42M | 9.26% | $205.80M | 3.52 | $522.12M | 3.61 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.44 | $70.66 | -4.56% | 22.78x | 8.14x | 5.28x | 36.42x | 0.41x | $667.65M | 8.38% | $219.64M | 1.86 | $9.83B | 15.76 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $49.67 | $40.92 | 21.39% | 35.48x | 12.50x | 2.95x | 1.55x | 0.50x | $767.06M | 8.02% | $6.21B | 32.27 | $7.96B | 16.49 | ||
| RPRX | ROYALTY PHARMA PLC | $52.07 | $39.97 | 30.29% | 27.26x | 9.76x | 9.32x | 3.02x | 0.59x | $2.34B | 10.29% | $9.94B | 22.75 | $38.35B | 32.97 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $207.89 | $95.89 | 116.80% | 26.32x | 23.07x | 15.06x | 4.18x | 1.29x | $122.22M | 2.96% | $997.32M | 50.16 | $4.50B | 19.97 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $229.55 | $48.85 | 369.92% | 488.40x | 8.89x | 3.20x | 3.18x | 1.67x | $1.30B | 9.13% | $4.53B | 73.22 | $17.96B | 26.61 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $53.64 | $15.93 | 236.75% | 54.73x | 48.63x | 5.44x | 6.81x | 1.68x | $164.23M | 4.00% | $605.69M | 7.92 | $3.95B | 35.39 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.83 | $35.93 | -16.98% | 11.79x | 8.13x | 1.92x | 1.90x | 0.45x | $341.79M | 19.82% | $910.35M | 15.75 | $1.30B | 5.47 | ||
| TECH | BIO-TECHNE CORP | $44.43 | $15.42 | 188.16% | 62.58x | 22.60x | 5.74x | 3.34x | 1.28x | $269.60M | 3.88% | $2.09B | 13.34 | $7.04B | 27.49 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.58 | $5.75 | -55.11% | 9.56x | 3.78x | 2.42x | 2.82x | 0.20x | $7.24M | 4.88% | $52.93M | 0.92 | $95.73M | 6.18 | ||
| TGTX | TG THERAPEUTICS INC | $39.48 | $18.66 | 111.59% | 12.26x | 26.30x | 8.14x | 10.36x | 8.02x | -$14.19M | -0.25% | $583.13M | 4.04 | $6.35B | 42.34 | ||
| EXEL | EXELIXIS INC | $49.84 | $30.91 | 61.25% | 15.97x | 15.13x | 5.42x | 6.47x | 1.16x | $917.69M | 7.13% | $1.94B | 7.49 | $12.47B | 11.81 | ||
| UTHR | UNITED THERAPEUTICS CORP | $566.99 | $247.86 | 128.75% | 19.36x | 19.51x | 7.78x | 4.08x | 2.05x | $1.02B | 4.12% | $5.90B | 135.66 | $22.79B | 13.30 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.70 | $2.46 | 50.13% | 15.42x | 15.64x | 2.27x | 3.58x | 1.04x | $4.11M | 1.38% | $82.33M | 1.03 | $230.71M | 10.86 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.23 | $14.93 | 109.19% | 17.25x | 16.23x | 6.40x | 3.77x | 1.96x | $208.13M | 5.45% | $1.01B | 8.28 | $3.07B | 9.16 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $436.58 | $170.08 | 156.68% | 25.67x | 22.31x | 9.08x | 5.72x | 1.83x | $3.71B | 3.34% | $19.36B | 76.20 | $107.30B | 19.90 | ||
| VCYT | VERACYTE INC | $41.50 | $12.36 | 235.65% | 37.39x | 36.88x | 6.09x | 2.46x | 2.15x | $155.34M | 4.71% | $1.34B | 16.90 | $3.09B | 26.82 | ||
| MDXG | MIMEDX GROUP INC | $3.59 | $1.56 | 129.43% | 17.10x | -50.28x | 1.37x | 2.20x | 2.65x | $69.36M | 13.01% | $242.94M | 1.64 | $392.54M | 7.21 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.91 | $1.75 | 9.45% | 10.05x | 8.79x | 2.00x | 2.29x | 0.87x | $13.00M | 8.53% | $67.23M | 0.84 | $120.66M | 5.40 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $629.68 | $443.79 | 41.89% | 14.80x | 13.32x | 4.39x | 2.10x | 0.97x | $4.11B | 6.28% | $31.42B | 302.15 | $65.76B | 11.45 | ||
| INCY | INCYTE CORP | $95.19 | $66.28 | 43.62% | 13.06x | 12.09x | 3.54x | 3.38x | 1.15x | $1.45B | 7.65% | $5.62B | 28.21 | $15.59B | 8.33 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.01 | $4.61 | 268.98% | 28.35x | 4.88x | 0.82x | 1.19x | 3.97x | $109.24M | 6.11% | $1.51B | 14.34 | $2.37B | 28.62 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.